Yang et al. [29] observed that KRT6A was up-regulated in LUAD tissues and overexpression of it was associated with poor prognosis; meanwhile, KRT6A promoted migration and proliferation of lung cancer cells, indicating that KRT6A could be used as a prognostic biomarker for LUAD. The gene discussed is KRT6A; the disease is lung cancer.